Fibrosis Progression According to Epithelial-Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA

Planned Randomized Conversion From Tacrolimus to Sirolimus-Based Immunosuppressive Regimen inDe NovoKidney Transplant Recipients

(2013) H. T. Silva et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Epithelial phenotypic changes are associated with a tubular active fibrogenic process in human renal grafts

(2013) Yi-Chun Xu-Dubois et al.   HUMAN PATHOLOGY

Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

(2012) L. Mjörnstedt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine

(2012) Fuad S. Shihab et al.   CLINICAL TRANSPLANTATION

Long-term Impact of Subclinical Inflammation Diagnosed by Protocol Biopsy One Year After Renal Transplantation

(2011) A. Thierry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy

(2011) R. Snanoudj et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

(2011) Y. Lebranchu et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

(2011) Wilhelm Kriz et al.   JOURNAL OF CLINICAL INVESTIGATION

Epithelial-to-Mesenchymal Transition Predicts Cyclosporine Nephrotoxicity in Renal Transplant Recipients

(2011) M. Hazzan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

(2011) Klemens Budde et al.   LANCET

Autophagy Is a Component of Epithelial Cell Fate in Obstructive Uropathy

(2010) Ling Li et al.   AMERICAN JOURNAL OF PATHOLOGY

Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

(2010) B. Sis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Mechanistic connection between inflammation and fibrosis

(2010) Soo Bong Lee et al.   KIDNEY INTERNATIONAL

Optimal Everolimus Concentration Is Associated With Risk Reduction for Acute Rejection in De Novo Renal Transplant Recipients

(2010) Laurence Chan et al.   TRANSPLANTATION

Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial

(2010) Markus Guba et al.   TRANSPLANTATION

Intragraft Tubular Vimentin and CD44 Expression Correlate With Long-Term Renal Allograft Function and Interstitial Fibrosis and Tubular Atrophy

(2010) Jesper Kers et al.   TRANSPLANTATION

Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis

(2009) Benjamin D. Humphreys et al.   AMERICAN JOURNAL OF PATHOLOGY

Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus

(2009) A. Servais et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study

(2009) Y. Lebranchu et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Identifying Specific Causes of Kidney Allograft Loss

(2009) Z. M. El-Zoghby et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Early Epithelial Phenotypic Changes Predict Graft Fibrosis

(2008) A. Hertig et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?

(2008) Björn Nashan   Transplantation Reviews